A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin. (Q48407108)

11 February 2018

title

A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin. (English)

1 reference

11 February 2018

1 reference

1 reference

1 reference

2

1 reference

11 February 2018

Calum Sutherland

5

1 reference

11 February 2018

author name string

A D McNeilly

1

1 reference

11 February 2018

D J K Balfour

3

1 reference

11 February 2018

C A Stewart

4

1 reference

11 February 2018

publication date

18 August 2012

1 reference

11 February 2018

published in

Diabetologia

1 reference

11 February 2018

volume

55

1 reference

11 February 2018

issue

11

1 reference

11 February 2018

page(s)

3061-3070

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s00125-012-2686-y

exact match

0 references

cites work

The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Diabetes, impaired fasting glucose, and development of cognitive impairment in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Hyperinsulinemia and risk of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Neurodegenerative disorders associated with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Insulin and cognitive function in humans: experimental data and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Glycogen synthase kinase 3: a drug target for CNS therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

The glamour and gloom of glycogen synthase kinase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Diabetes and insulin in regulation of brain cholesterol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Advanced glycation end product level, diabetes, and accelerated cognitive aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Diabetes and cognitive decline in elderly African Americans: a 15-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Obese Adolescents with Type 2 Diabetes Mellitus Have Hippocampal and Frontal Lobe Volume Reductions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Glucose treatment reduces memory deficits in young adult rats fed high-fat diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Synthesis and function of 3-phosphorylated inositol lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Perspective: The insulin signaling system--a common link in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

How obesity causes diabetes: not a tall tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Adipocytokines and the metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Insulin promotes rat retinal neuronal cell survival in a p70S6K-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Development of glutamate neurotoxicity in cortical cultures: induction of vulnerability by insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Peripheral hyperinsulinemia promotes tau phosphorylation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

High fat feeding promotes simultaneous decline in insulin sensitivity and cognitive performance in a delayed matching and non-matching to position task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Determination of metformin in human plasma using hydrophilic interaction liquid chromatography–tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Characterization of a protein kinase B inhibitor in vitro and in insulin-treated liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

High-fat diets, insulin resistance and declining cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Improving metabolic control leads to better working memory in adults with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Metformin: new understandings, new uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Cellular and molecular mechanisms of metformin: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2686-Y

PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?

21 January 2018

1 reference

12 December 2020

In vivo regulation of cell death by embryonic (pro)insulin and the insulin receptor during early retinal neurogenesis.

1 reference

12 December 2020

What Are the bona fide GSK3 Substrates?

1 reference

12 December 2020

Factor structure of a modified version of the wisconsin card sorting test: an analysis of executive deficit in Alzheimer's disease and mild cognitive impairment

1 reference

12 December 2020

Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man

1 reference

12 December 2020

Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease

1 reference

12 December 2020

10.1007/S00125-012-2686-Y

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

22898768

1 reference

11 February 2018